Report updated May 20, 2026
GLP-1 Tracker: Pep
For individuals prescribed GLP-1 medications for weight loss who require a centralized tool for medication adherence, nutrition tracking, and progress monitoring.
GLP-1 Tracker: Pep is an established medical app that is free with in-app purchases. With a 4.6/5 rating from 2.3K reviews, it shows polarized user reception. Users particularly appreciate comprehensive tracking of glp-1 medication and progress metrics keeps users focused on their health goals, though inaccurate ai meal calorie estimation poses potential health risks for users tracking weight loss remains a common concern.
What is GLP-1 Tracker: Pep?
Pep is a medical tracking app for GLP-1 medication users, providing injection reminders, nutrition logging, and progress visualization on iOS and Android.
Users hire Pep to manage the high-stakes, multi-step requirements of GLP-1 treatment in one place, reducing the cognitive load of tracking medication, side effects, and nutrition simultaneously.
Current Momentum
v2.0 · 6d ago
Active- Added support for oral GLP-1 pills.
- Shipped performance optimizations for logging.
Active Nemesis
Medisafe Medication Management
By MediSafe
Other Rivals
7-Day Rank Pulse 🇺🇸
MedicalNo ranking data
Rating Pulse 🇺🇸
Recent User Mood
What makes this app unique?
What Does It Look Like?
What Are The Key Features?
Logs injectable and oral medication doses including Ozempic, Wegovy, Mounjaro, and Zepbound
Uses photo and barcode recognition to estimate calories, protein, and fiber via FatSecret API
Prompts users to alternate injection locations to prevent tissue damage
How much does it cost?
- Free version with core tracking features
- Premium membership for advanced tracking and insights
Freemium model uses a free-to-download entry point with a premium gate for advanced nutrition and progress analytics.
Who Built It?
Shred Apps
Providing specialized fitness and medical tracking tools tailored to specific user demographics and health journeys.
Portfolio
13
Apps
What other apps does Shred Apps make?
Stew Smith's Push-Up Push
Gym Workout Planner For Women
Navy SEAL Training & Exercises
Gym Workout For Men
Big Butt & Leg Workout Planner
Abs Workout – Men
Explore the full Shred Apps report
Portfolio breakdown, audience, momentum, and every app published by Shred Apps.
What do users think recently?
Low confidence · Latest 64 of 112 total reviews analyzed · Based on 112 reviews. Signal may be noisy.
How did the latest release land?
What is the recent mood?
Recent user voice shows a mixed sentiment. Users appreciate comprehensive tracking of glp-1 medication and progress metrics keeps users focused on their health goals, but report inaccurate ai meal calorie estimation poses potential health risks for users tracking weight loss.
What Users Love
What Frustrates Users
What Users Want
How have ratings & review volume moved?
Rating, review sentiment, and total reviews over time, with release markers showing the post-launch impact.
Vertical markers = app releases. Hover any release for the post-release impact delta.
View the full user-sentiment analysis
Mood gauge, ratings & review-volume history, every praise / complaint / request, and sentiment over time.
What is the competitive landscape for GLP-1 Tracker: Pep?
How's The Medical Market?
How does it evolve in the Medical market?
Pep currently holds a #64 Grossing position in the US Medical category. The gap between its utility-driven free user base and its grossing rank indicates that the premium gate for AI nutrition features is not yet converting at scale.
Rank progression
100 active rankings tracked — 30-day window
Which niche is GLP-1 Tracker: Pep in?
to manage medication and track health progress
Explore the full Diabetes Management Trackers niche
Every app in this space — 46 tracked, the niche's live rankings, and Marlvel's editorial take on the job-to-be-done.
The rivals identified
Nemeses(1)
Shotsy is the direct market leader in the GLP-1 niche, offering specialized tracking for medication cycles that mirrors Pep’s core value proposition.
Contenders(4)
WellView competes by providing pharmacy-centric utility, specifically targeting the cost and access pain points of GLP-1 users.
It competes for the same user base by offering robust logging features for chronic condition management and medication adherence.
This app targets the same health-conscious demographic managing metabolic conditions, overlapping with Pep’s side-effect and progress monitoring.
This app competes by controlling the supply chain and prescription fulfillment process for the same medications Pep users are tracking.
Same space(3)
It competes by offering high-utility device management, appealing to users who require precision in their medication delivery.
This app provides clinical-grade coaching and data management, competing for users who want a professional health management experience.
Stelo competes by offering hardware-backed health insights that provide a more scientific alternative to manual tracking.
Compare GLP-1 Tracker: Pep against every rival
All rivals in one side-by-side table — identity, store metrics, ratings & sentiment, and strategic intel — plus a head-to-head page for each.
The outtake for GLP-1 Tracker: Pep
Strengths to defend, gaps to attack
Core Strengths
- Centralized GLP-1-specific workflow reduces user cognitive load
- Injection site rotation tracking creates specialized health-safety switching costs
Critical Frictions
- AI meal scanner calorie variance poses health-safety risks
- Billing friction causes unauthorized charges
- Technical regressions in dosage logging erode trust
Growth Levers
- Integration with wearable devices would automate biometric data
- Expansion into professional-grade PDF reporting for endocrinologists
Market Threats
- Telehealth-integrated platforms like Hims capture the entire value chain
- Hardware-tethered apps like Libre by Abbott create high barriers to entry
What are the next best moves?
Ship manual override for AI food scanner
AI calorie inaccuracy is a top complaint, threatening user health-safety trust.
Trade-off: Pause the wearable integration sprint to prioritize core data accuracy.
Audit billing and cancellation flows
Unauthorized charge reports are rising, creating significant brand drag.
Trade-off: Same-quarter capacity available — no major lever displaced.
A counter-intuitive read
The reliance on AI food scanning is a strategic liability, not a differentiator, because the health-safety risk of inaccurate calorie tracking outweighs the convenience for the target medical audience.
Feature Gaps vs Competitors
- Clinical-grade drug-to-drug interaction warnings (available in Medisafe)
- Family caregiver accounts (available in Medisafe)
- Direct EHR integration (available in athenaPatient)
Key Takeaways
Pep succeeds by centralizing GLP-1 adherence, but technical instability and AI inaccuracy threaten its retention, so the PM must prioritize core data reliability over new feature expansion to stabilize the user base.
Where Is It Heading?
Mixed Signals
The GLP-1 tracking market is consolidating around tools that offer clinical-grade reliability, leaving Pep exposed to churn if its AI-driven features continue to underperform. The PM must pivot from feature-heavy updates to stability-first engineering to prevent users from migrating to more established medical-management platforms.
Technical regressions in the latest update break dosage logging, which directly erodes the daily habit and increases churn risk.
Recent updates focused on stability and oral pill support, indicating a shift toward maintaining core utility over aggressive feature expansion.